⌘ KStart free
0%
Skip to lesson

neuro

Neuromuscular Junction Disorders: MG, LEMS and Botulism

Locate the failed step in neuromuscular transmission, compare MG, LEMS and botulism, and connect diagnostic patterns with treatment and crisis recognition.

Locate the failure before naming the disease. A nerve must admit calcium, release acetylcholine and activate receptors on muscle. MG, LEMS and botulism interfere at different points. Their patterns of weakness are useful because they reveal those different mechanisms, not because a single symptom is infallible. [1] [3]

Build a normal signal, then interrupt it

From nerve signal to muscle responseCalcium entry triggers vesicle fusion. Released acetylcholine activates nicotinic receptors on muscle.The normal junctionNerve endingCalcium enters; vesicles fuseCaDockAcetylcholine crossesMuscle receptors respond
Calcium entry triggers vesicle fusion. Released acetylcholine activates nicotinic receptors on muscle.

Image: Bone Wizardry.

An action potential reaches the nerve terminal and opens voltage-gated calcium channels. Calcium enters the terminal and helps trigger vesicle fusion. Released acetylcholine binds nicotinic acetylcholine receptors on the muscle endplate. If the endplate response reaches threshold, the muscle produces an action potential. [1] [3]

The normal junction has a safety margin. Its chemical signal usually exceeds what is needed to activate a muscle fiber. A disorder can shrink that margin before completely abolishing transmission. Weakness therefore does not require every channel, vesicle or receptor to stop working. [1]

In MG, antibody-mediated loss or dysfunction of the postsynaptic apparatus reduces that safety margin. During repeated activity, the usual variation in transmitter release exposes the impaired margin and transmission can fail. Receptors are not literally consumed one by one whenever the patient contracts a muscle. [1]

In LEMS, antibodies commonly target presynaptic P/Q-type calcium channels. Less calcium enters, so less acetylcholine is released. Brief repeated activation can increase residual calcium and temporarily improve transmission. This is facilitation, not elimination of the antibodies. [1]

Botulinum toxin instead damages proteins needed for vesicle fusion. The distinction is calcium entry, vesicle fusion, or postsynaptic response. Keeping these three locations separate makes the treatment mechanisms much easier to predict. [3]

Read the pattern across the whole examination

Historical clinical photograph showing partial drooping of the right eyelid in a patient with myasthenia gravis.
Historical clinical example from a 2008 case report: partial right ptosis. The image illustrates an examination finding, not a standalone diagnostic test. Mohankumar Kurukumbi, Roger L.
Image: Weir, Janaki Kalyanam, Mansoor Nasim and Annapurni Jayam-Trouth. Image source. CC BY 2.0. None; original image Select the photograph to open it at full size.
Localize the defectLEMS reduces calcium entry. Botulinum toxin disrupts vesicle fusion. MG reduces effective postsynaptic receptor function.Three different failuresLEMS: calcium entrySignal reducedBotulism: fusionSignal reducedMG: muscle receptorsSignal reduced
LEMS reduces calcium entry. Botulinum toxin disrupts vesicle fusion. MG reduces effective postsynaptic receptor function.

Image: Bone Wizardry.

MG often begins with fluctuating ptosis or diplopia. Chewing, speech, swallowing, neck strength and proximal limb strength may also be affected. Symptoms often worsen with sustained activity and improve with rest. Pupils and sensation are usually normal; tendon reflexes are generally preserved. [1]

LEMS commonly causes proximal leg weakness, reduced reflexes and autonomic complaints such as dry mouth or constipation. Reflexes or strength may briefly improve after exertion. Sustained exertion can still fatigue a patient, so the teaching rule is brief facilitation rather than an unlimited benefit from exercise. [1]

Botulism often develops over hours to days, beginning with cranial or bulbar findings before descending weakness. Pupillary or autonomic involvement and a relevant exposure support the diagnosis. A food cluster is helpful when present; its absence does not exclude wound or infant botulism. [3] [7]

Normal sensation supports a junctional disorder, but it does not prove one. Asymmetry, a sensory level, upper-motor-neuron signs, marked pain or ataxia should broaden the differential. Guillain-Barre variants and brainstem disease can overlap with some of these findings. [1] [3]

Case 2

A man with proximal leg weakness has dry mouth and reduced knee reflexes. A brief contraction makes the reflex easier to elicit. Which diagnosis best fits?

Show answer and explanations for case 2
  1. A. Lambert-Eaton myasthenic syndrome (Best answer)

    Proximal weakness, autonomic symptoms and brief post-exercise facilitation are characteristic of LEMS.

  2. B. Myasthenia gravis (Why this does not fit)

    MG generally preserves reflexes and pupils and more often has prominent fatigable ocular symptoms.

  3. C. A pure sensory neuropathy (Why this does not fit)

    Sensory dysfunction alone does not account for this facilitated motor pattern.

  4. D. Generalized tetanus (Why this does not fit)

    Rigidity and painful spasms are different from this flaccid weakness.

Takeaway: Use the combination of strength, reflexes and autonomic findings.

Case sources: [1]

Use tests to support the localization

Different patterns during repeated stimulationConceptual traces, not patient measurements or diagnostic thresholds. Low-frequency decrement is not specific to MG; stimulation protocol matters.Response to repetitionNormalMG: reduced safety marginLEMS: brief facilitationSuccessive nerve signals
Conceptual traces, not patient measurements or diagnostic thresholds. Low-frequency decrement is not specific to MG; stimulation protocol matters.

Image: Bone Wizardry.

For suspected autoimmune MG, acetylcholine-receptor antibodies are commonly tested first. If these are absent and clinical suspicion remains, MuSK testing and appropriate specialist-directed testing can follow. Negative antibodies do not exclude MG; sensitivity differs between ocular and generalized disease. [1]

Low-frequency repetitive nerve stimulation may show a decrement in MG. Single-fiber testing can identify impaired neuromuscular transmission, but an abnormal result is not specific to one disease. Interpret the clinical pattern, antibody findings and electrophysiology together. [1]

LEMS may show both a low-frequency decrement and a post-exercise or high-frequency increment. A low resting compound muscle action potential adds context. Botulism can also produce facilitation. One waveform or a single arbitrary cutoff cannot substitute for the full interpretation. [1] [3]

An ice-pack test may support ocular MG when ptosis improves, but it is not a standalone confirmation. Edrophonium is mainly of historical teaching interest and has important cardiac risks. Do not delay crisis treatment to provoke a diagnostic drug response. [1] [8]

Chest imaging evaluates thymic pathology in MG. LEMS warrants assessment for an associated malignancy, especially small-cell lung cancer. Negative initial screening does not necessarily end surveillance; subsequent testing is tailored to individual risk and specialist guidance. [1] [2]

Case 4

Repetitive nerve stimulation shows a low resting motor response and a large increase after brief exercise. How should the finding be interpreted?

Show answer and explanations for case 4
  1. A. It is the defining response of a sensory neuropathy (Why this does not fit)

    The test measures motor transmission, not sensory function.

  2. B. It supports a presynaptic transmission disorder in the appropriate context (Best answer)

    An increment supports LEMS or another presynaptic disorder; clinical context remains necessary.

  3. C. A low-frequency decrement would exclude LEMS (Why this does not fit)

    LEMS can also show low-frequency decrement.

  4. D. It independently proves LEMS in every patient (Why this does not fit)

    Botulism can also facilitate, so the finding is not uniquely diagnostic.

Takeaway: The stimulation protocol and the clinical pattern belong together.

Case sources: [1] [3]

Match treatment to the part that failed

Pyridostigmine slows acetylcholine breakdown. It can improve MG symptoms by giving available acetylcholine more opportunity to activate the remaining receptors. It does not remove pathogenic antibodies. Diarrhea, abdominal cramping, sweating, salivation and bradycardia are cholinergic adverse effects. [1] [8]

Disease-modifying MG care may require corticosteroids and steroid-sparing immunotherapy. Antibody status, severity, comorbidity and treatment response guide escalation. Complement-directed and FcRn-directed therapies are additional options for selected patients; a basic mechanism lesson is not a complete prescribing algorithm. [1]

Thymoma requires surgical evaluation. Thymectomy can also benefit selected adults with generalized AChR-antibody-positive MG without thymoma. Eligibility and expected benefit are not identical for ocular-only, MuSK-positive or other subgroups. It is not an immediate rescue treatment and does not guarantee remission. [2]

Amifampridine blocks potassium channels and prolongs presynaptic depolarization, helping calcium entry and acetylcholine release in LEMS. A history of seizures is a contraindication to FIRDAPSE. Treat an associated malignancy and consider immune-directed treatment when needed; tumor response does not guarantee complete resolution of weakness. [1] [5]

Botulism requires prompt specialist consultation, antitoxin when indicated and respiratory support when needed. An antitoxin works outside the nerve ending to prevent additional blockade. It does not immediately repair a terminal already affected by toxin. [3]

MG can increase sensitivity to nondepolarizing blockers such as vecuronium. MG can produce relative resistance to depolarizing succinylcholine, unlike its increased sensitivity to nondepolarizing blockade. The response is variable, so the rule is not that every paralytic behaves identically. Anesthesia planning requires individualized monitoring, not a fixed dose extrapolated from a teaching diagram. [11] [14] [15]

Recognize a crisis without delaying support

New respiratory or severe bulbar weakness is an emergency. In MG, declining ventilatory strength, ineffective cough and inability to handle secretions require close monitoring and experienced airway assessment. A reassuring oxygen saturation does not exclude dangerous hypoventilation. [1] [8]

A more negative inspiratory pressure represents a stronger effort. A value becoming less negative, for example from -50 to -15 cm H2O, indicates weakening. This example teaches direction, not a universal intubation threshold. Respiratory trends, swallowing, cough, fatigue and the entire examination determine urgency. [1] [8]

Acute MG rescue treatment commonly uses plasma exchange or intravenous immunoglobulin (IVIG), alongside airway and intensive-care support when indicated. Steroids or thymectomy alone do not provide immediate rescue. Pyridostigmine may be held in an intubated patient to reduce secretions, with subsequent treatment individualized. [1] [8]

Cholinergic toxicity can also cause weakness, but excessive secretions, diarrhea, sweating, bradycardia, miosis and fasciculations suggest excess cholinergic activity. A usual prescribed dose alone does not establish toxicity. Do not use an edrophonium challenge to settle the diagnosis during respiratory deterioration. [8]

Review new medicines and intercurrent infection. Aminoglycosides, fluoroquinolones, magnesium and some other medicines can aggravate MG. Hydroxychloroquine can worsen or precipitate MG and requires caution, rather than a blanket reassurance that it has no meaningful effect. Corticosteroids can transiently worsen weakness early in treatment. [4]

Organophosphate poisoning can produce muscarinic secretions and nicotinic weakness. Atropine blocks muscarinic effects; pralidoxime can reactivate susceptible organophosphate-inhibited acetylcholinesterase before the enzyme becomes nonreactivatable. Airway support and toxicology consultation remain essential. This mechanism comparison is not an automatic treatment instruction for pyridostigmine overdose or every carbamate exposure. [12]

Case 26

Serial negative inspiratory force changes from -50 to -15 cm H2O in a patient with worsening MG. What does that directional change indicate?

Show answer and explanations for case 26
  1. A. A weaker inspiratory effort (Best answer)

    A less negative pressure indicates weaker inspiratory effort; airway decisions also require the whole clinical assessment.

  2. B. A stronger effort because -15 is numerically greater (Why this does not fit)

    The magnitude of negative inspiratory pressure has decreased.

  3. C. A universal requirement to wait for one exact cutoff (Why this does not fit)

    Respiratory trends, bulbar function and clinical deterioration matter beyond a single cutoff.

  4. D. A measurement of sensory nerve recovery (Why this does not fit)

    This assesses inspiratory muscle performance rather than sensation.

Takeaway: Less negative inspiratory pressure means less inspiratory strength.

Case sources: [1] [8]

Keep the important exceptions in view

MuSK-positive MG remains a postsynaptic autoimmune disorder. Bulbar and respiratory involvement can be prominent. Response to pyridostigmine may be limited, and rituximab is an important specialist-directed option when the response to initial immunotherapy is unsatisfactory. Negative AChR antibodies do not turn this into LEMS. [1] [2]

Double-seronegative presentations need careful specialist evaluation; neither a negative panel nor the distribution of weakness proves an alternative diagnosis. Consider electrophysiology, additional testing when appropriate, and competing causes before committing to long-term treatment. [1]

Congenital myasthenic syndromes are genetic transmission disorders, not simply infant versions of autoimmune MG. Age at onset and severity vary. Treatment depends on the molecular defect. COLQ-related disease impairs anchoring of endplate acetylcholinesterase; acetylcholinesterase inhibitors may be ineffective or worsen some congenital subtypes. [1] [6]

Pregnancy calls for coordinated neurologic and obstetric care. Maintaining disease control matters, but medication selection must be reviewed individually. Oral pyridostigmine is commonly used. Mycophenolate is avoided in pregnancy; other immune therapies require a specific risk-benefit discussion rather than stopping every medicine or declaring all drugs safe. [8]

Neuromuscular weakness after immune-checkpoint therapy may coexist with myositis or myocarditis. This can be rapidly serious and needs urgent specialist evaluation. The same basic discipline still works: localize the problem, assess respiratory risk and interpret the pattern rather than relying on one familiar label. [2]

After IVIG, a low reported sodium requires assessment of tonicity and measurement method. Increased serum protein can cause pseudohyponatremia with indirect measurement, while true hyponatremia can also occur in some settings. Do not label every post-infusion sodium result as the same mechanism. [9] [10]

Clinical practice

Case 1

A woman has fluctuating ptosis and chewing fatigue. Pupils and reflexes are normal. Chest imaging identifies a thymic mass. Which antibody is most consistent with the neuromuscular presentation?

Show answer and explanations for case 1
  1. A. LRP4 antibodies (Why this does not fit)

    LRP4 is a recognized target in a smaller MG subgroup, but AChR antibodies are the most likely association with this presentation and thymic mass.

  2. B. P/Q-type calcium-channel antibodies (Why this does not fit)

    These support presynaptic LEMS, more often with reduced reflexes and autonomic symptoms.

  3. C. Acetylcholine-receptor antibodies (Best answer)

    AChR-antibody-positive MG is the strongest fit for fluctuating ocular and bulbar weakness with a thymic mass.

  4. D. MuSK antibodies (Why this does not fit)

    MuSK-positive MG can cause bulbar weakness, but thymic pathology is much more characteristic of AChR-positive disease.

Takeaway: Fluctuating ocular and bulbar weakness fits MG.

Case sources: [1] [2]

Case 3

A patient with previously stable MG becomes markedly weaker after starting gentamicin for an infection. Which explanation should be considered?

Show answer and explanations for case 3
  1. A. Gentamicin reliably improves the MG safety margin (Why this does not fit)

    Its neuromuscular effects can worsen, not reliably improve, transmission.

  2. B. This proves pyridostigmine overdose (Why this does not fit)

    A new antibiotic exposure does not establish cholinergic toxicity.

  3. C. The worsening excludes MG (Why this does not fit)

    Medication-associated exacerbation is compatible with MG.

  4. D. Additional impairment of neuromuscular transmission (Best answer)

    Aminoglycosides can aggravate MG; the infection itself also needs assessment as a precipitant.

Takeaway: Check both new medications and intercurrent illness during deterioration.

Case sources: [4]

Case 5

A 5-month-old infant develops constipation, poor suck and generalized hypotonia. The family reports honey exposure. Which mechanism most likely explains the illness?

Show answer and explanations for case 5
  1. A. SMN1-associated anterior horn cell degeneration (Why this does not fit)

    Spinal muscular atrophy is a motor-neuron disorder, not a consequence of honey-associated spore exposure.

  2. B. Intestinal colonization with local toxin production (Best answer)

    Swallowed spores can colonize the infant intestine and produce toxin there.

  3. C. Preformed toxin absorbed from preserved food (Why this does not fit)

    This is the foodborne-intoxication mechanism, not the usual mechanism of honey-associated infant botulism.

  4. D. Transplacental transfer of maternal AChR antibodies (Why this does not fit)

    This can cause transient neonatal myasthenia but does not fit the toxin-associated constipation and exposure pattern.

Takeaway: Infant botulism involves spores and intestinal toxin production.

Case sources: [3] [7]

Case 6

A patient has fatigable bulbar weakness and supportive neuromuscular testing, but AChR antibodies are absent. The specialist next assesses the common antibody associated with the postsynaptic receptor-clustering kinase. Which test is appropriate?

Show answer and explanations for case 6
  1. A. P/Q-type calcium-channel antibodies (Why this does not fit)

    These target presynaptic channels and support LEMS, not the postsynaptic kinase disorder.

  2. B. MuSK antibodies (Best answer)

    MuSK is muscle-specific kinase, a postsynaptic receptor-clustering protein; its antibodies can cause MG despite negative AChR testing.

  3. C. LRP4 antibodies (Why this does not fit)

    LRP4 participates in the clustering pathway but is not the muscle-specific kinase named in the question.

  4. D. Acetylcholine-receptor antibodies (Why this does not fit)

    AChR antibodies target the receptor itself rather than MuSK; the existing assay is negative in this patient.

Takeaway: AChR-negative does not mean MG-negative.

Case sources: [1] [2]

Case 7

A patient with MG has respiratory failure and is intubated. Which treatment is commonly used for rapid disease-specific rescue?

Show answer and explanations for case 7
  1. A. Urgent thymectomy as the only intervention (Why this does not fit)

    Thymectomy is not an immediate rescue for respiratory failure.

  2. B. Waiting several months for a steroid-sparing agent to work (Why this does not fit)

    A delayed maintenance effect cannot address an acute crisis.

  3. C. Plasma exchange or intravenous immunoglobulin (Best answer)

    Both are established rapid immunomodulatory treatments for myasthenic crisis alongside intensive supportive care.

  4. D. Escalating pyridostigmine alone (Why this does not fit)

    This does not provide appropriate crisis rescue and can increase secretions.

Takeaway: Rescue treatment and breathing support proceed together.

Case sources: [1] [8]

Case 8

A new diagnosis of LEMS is confirmed in an older adult with a substantial smoking history. Which associated condition particularly warrants evaluation?

Show answer and explanations for case 8
  1. A. Lung adenocarcinoma (Why this does not fit)

    A lung malignancy is relevant in a smoker, but small-cell histology is the classic LEMS association.

  2. B. Thymoma (Why this does not fit)

    Thymoma is more characteristically associated with MG than LEMS.

  3. C. Pancreatic adenocarcinoma (Why this does not fit)

    This is not the characteristic paraneoplastic association of LEMS.

  4. D. Small-cell lung cancer (Best answer)

    This is the characteristic malignancy associated with paraneoplastic LEMS.

Takeaway: LEMS can be the first indication of an underlying malignancy.

Case sources: [1]

Case 9

An adult develops diplopia and dysphagia followed by descending weakness after a shared preserved-food meal. Which target explains the likely disorder?

Show answer and explanations for case 9
  1. A. Myelin on a single sensory nerve (Why this does not fit)

    The distribution is cranial, bulbar and generalized motor rather than a single sensory territory.

  2. B. Postsynaptic receptors targeted by AChR antibodies (Why this does not fit)

    That is characteristic of autoimmune MG rather than this acute food-associated syndrome.

  3. C. Proteins required for presynaptic vesicle fusion (Best answer)

    Botulinum toxin cleaves SNARE proteins and reduces acetylcholine release.

  4. D. Presynaptic channels targeted by LEMS antibodies (Why this does not fit)

    LEMS is not the best explanation for an acute shared-food cluster.

Takeaway: Botulism disrupts release, not primarily the muscle receptor.

Case sources: [3]

Case 10

A woman notices double vision and a drooping eyelid after prolonged reading, with improvement after rest. Which accompanying finding is most consistent with uncomplicated ocular MG?

Show answer and explanations for case 10
  1. A. Stimulus-induced generalized spasms (Why this does not fit)

    That pattern is unlike the usual fatigable weakness of MG.

  2. B. Normal pupillary responses (Best answer)

    MG affects skeletal neuromuscular transmission and usually spares pupils.

  3. C. Fixed dilated pupils as a defining requirement (Why this does not fit)

    Pupillary dysfunction suggests another or additional process.

  4. D. A sensory level across the chest (Why this does not fit)

    A sensory level suggests spinal cord localization rather than ocular MG.

Takeaway: Ocular muscle weakness and pupillary dysfunction are different findings.

Case sources: [1]

Case 11

A patient with fluctuating ptosis has improved eyelid elevation after an ice-pack test. What is the best interpretation?

Show answer and explanations for case 11
  1. A. The response excludes all competing causes of ptosis (Why this does not fit)

    Other findings and appropriate testing still matter.

  2. B. The response proves LEMS (Why this does not fit)

    This is not the defining bedside finding of LEMS.

  3. C. The result supports ocular MG but requires clinical correlation (Best answer)

    A bedside response can support suspicion without independently confirming the diagnosis.

  4. D. The response proves every case of MG (Why this does not fit)

    No single bedside response should replace the broader diagnostic evaluation.

Takeaway: A supportive bedside test is not a standalone diagnosis.

Case sources: [1]

Case 12

In LEMS, a weak motor response becomes temporarily larger after brief repeated activation. What explains this facilitation?

Show answer and explanations for case 12
  1. A. Residual calcium accumulates within the presynaptic terminal (Best answer)

    Brief repeated activation raises residual calcium and improves acetylcholine release.

  2. B. Axonal conduction velocity increases (Why this does not fit)

    The demonstrated facilitation concerns transmitter release at the junction, not a primary improvement in axonal conduction.

  3. C. Acetylcholinesterase activity falls within the synaptic cleft (Why this does not fit)

    Slowing acetylcholine breakdown is not the mechanism of post-exercise LEMS facilitation.

  4. D. Postsynaptic receptor expression increases (Why this does not fit)

    The rapid facilitation is presynaptic and does not require new receptor expression.

Takeaway: Brief repetition can improve transmitter release without curing the disorder.

Case sources: [1]

Case 13

A patient with AChR-antibody-positive MG undergoes surgery. A small dose of the nondepolarizing blocker vecuronium produces a greater neuromuscular effect than expected. Which explanation best fits?

Show answer and explanations for case 13
  1. A. Relative resistance caused by depolarizing receptor activation (Why this does not fit)

    Vecuronium is nondepolarizing; relative resistance to succinylcholine is a different drug-class response.

  2. B. Increased sensitivity at a junction with a reduced postsynaptic safety margin (Best answer)

    Competitive nondepolarizing blockade can have an exaggerated effect when MG has already reduced effective transmission.

  3. C. Temporary facilitation caused by residual presynaptic calcium (Why this does not fit)

    This explains a larger response after brief exertion in LEMS, not amplified nondepolarizing blockade in MG.

  4. D. Prolonged block caused by reduced plasma cholinesterase activity (Why this does not fit)

    Plasma cholinesterase chiefly matters for drugs such as succinylcholine; it does not explain the characteristic vecuronium sensitivity here.

Takeaway: Nondepolarizing blockade can be amplified by the impaired MG safety margin.

Case sources: [11] [14]

Case 14

A patient has wound-associated botulism, while another became ill after a preserved-food meal. What is the main difference between their exposure mechanisms?

Show answer and explanations for case 14
  1. A. Toxin is produced at the wound versus ingested already formed (Best answer)

    The entry mechanism differs even though both ultimately reduce presynaptic acetylcholine release.

  2. B. Wound botulism is always an AChR-antibody disorder (Why this does not fit)

    It remains toxin-mediated rather than autoimmune MG.

  3. C. Only foodborne botulism affects the junction (Why this does not fit)

    Wound and foodborne disease can produce the same final neuromuscular syndrome.

  4. D. Every wound case must also involve a suspect meal (Why this does not fit)

    A food exposure is not required for wound botulism.

Takeaway: Different sources can produce the same transmission failure.

Case sources: [3]

Case 15

A patient with MG is being considered for hydroxychloroquine for a separate condition. Which statement is most accurate?

Show answer and explanations for case 15
  1. A. Hydroxychloroquine can worsen or precipitate MG and needs careful review (Best answer)

    The MGFA identifies this medicine as requiring caution; the indication and alternatives should be considered.

  2. B. Every patient should stop all immune therapy immediately (Why this does not fit)

    The appropriate plan is individualized medication review, not blanket withdrawal.

  3. C. It is the preferred symptomatic MG drug (Why this does not fit)

    Pyridostigmine, not hydroxychloroquine, is commonly used for symptomatic MG treatment.

  4. D. It has no meaningful effect on MG (Why this does not fit)

    That reassurance conflicts with recognized medication-associated exacerbations.

Takeaway: Review a medicine for its neuromuscular effects, not only its other indication.

Case sources: [4]

Case 16

A historical teaching case describes transient improvement in ptosis after edrophonium. Which mechanism and risk explain this test?

Show answer and explanations for case 16
  1. A. Direct destruction of MuSK antibodies (Why this does not fit)

    This is not antibody-depleting therapy.

  2. B. Brief acetylcholinesterase inhibition with risk of bradycardia (Best answer)

    Edrophonium increases acetylcholine persistence briefly; important cardiac effects limit this historical diagnostic approach.

  3. C. A reliable reason to delay treatment during respiratory failure (Why this does not fit)

    Provocative testing must not delay emergency airway or crisis management.

  4. D. Permanent regeneration of postsynaptic receptors (Why this does not fit)

    The brief effect does not regenerate receptors.

Takeaway: A historical test mechanism is not a current crisis-management instruction.

Case sources: [1] [8]

Case 17

A 35-year-old has generalized AChR-antibody-positive MG without thymoma. Symptoms remain burdensome despite treatment. Which discussion is appropriate?

Show answer and explanations for case 17
  1. A. Thymectomy has identical evidence for every MG subtype (Why this does not fit)

    Evidence and eligibility differ by antibody status and clinical subtype.

  2. B. Whether thymectomy is appropriate as part of long-term management (Best answer)

    Selected adults with this subtype may benefit even without a thymoma; the decision is individualized.

  3. C. Surgery replaces airway support during an acute crisis (Why this does not fit)

    It is not an emergency substitute for respiratory support.

  4. D. Thymectomy guarantees immediate remission (Why this does not fit)

    Benefit is not instantaneous or guaranteed.

Takeaway: Thymectomy is a subtype-specific long-term decision, not a universal cure.

Case sources: [2]

Case 18

A patient with LEMS receives effective treatment for associated small-cell lung cancer. Which expectation about weakness is most reasonable?

Show answer and explanations for case 18
  1. A. Neuromuscular symptoms may improve but can persist (Best answer)

    Cancer treatment can help paraneoplastic disease without guaranteeing complete resolution of transmission dysfunction.

  2. B. Cancer treatment can never affect LEMS (Why this does not fit)

    Treating the malignancy is an important part of management.

  3. C. Every symptom must resolve immediately after the first treatment (Why this does not fit)

    That is not a reliable expectation.

  4. D. Persistent weakness proves the diagnosis was incorrect (Why this does not fit)

    LEMS may persist despite tumor control.

Takeaway: Tumor control and neuromuscular recovery need separate assessment.

Case sources: [1]

Case 19

A patient with LEMS is prescribed amifampridine. How does it improve neuromuscular transmission?

Show answer and explanations for case 19
  1. A. It cleaves SNARE proteins (Why this does not fit)

    SNARE cleavage is the harmful mechanism of botulinum toxin.

  2. B. It removes the underlying tumor directly (Why this does not fit)

    It provides symptomatic treatment rather than cancer therapy.

  3. C. It blocks potassium channels and prolongs presynaptic depolarization (Best answer)

    Longer depolarization supports calcium entry and acetylcholine release through remaining functional channels.

  4. D. It replaces all destroyed muscle receptors (Why this does not fit)

    Its primary symptomatic action is presynaptic rather than receptor replacement.

Takeaway: Prolonging the nerve signal can improve presynaptic release.

Case sources: [1] [5]

Case 20

A patient has a convincing fatigable weakness pattern but negative AChR and MuSK antibody tests. What is the appropriate interpretation?

Show answer and explanations for case 20
  1. A. The patient cannot have MG (Why this does not fit)

    Seronegative MG exists, although competing diagnoses must be assessed.

  2. B. Further specialist evaluation is needed; negative antibodies do not exclude MG (Best answer)

    Clinical assessment, electrophysiology and evaluation for alternatives remain important.

  3. C. Bulbar weakness alone proves an unidentified antibody (Why this does not fit)

    Distribution alone does not establish a particular antibody or diagnosis.

  4. D. Any negative blood test proves a functional disorder (Why this does not fit)

    That conclusion is not justified by antibody testing.

Takeaway: A negative panel changes the evaluation, not the reality of the symptoms.

Case sources: [1]

Case 21

A child with congenital myasthenic syndrome has impaired anchoring of acetylcholinesterase at the endplate. Which gene is specifically associated with this mechanism?

Show answer and explanations for case 21
  1. A. DOK7 (Why this does not fit)

    DOK7 supports postsynaptic signaling and receptor clustering; it is not the collagen-like anchoring tail of acetylcholinesterase.

  2. B. SMN1 (Why this does not fit)

    SMN1 is associated with spinal muscular atrophy, a motor-neuron disorder rather than this anchoring defect.

  3. C. CHAT (Why this does not fit)

    CHAT encodes choline acetyltransferase and affects acetylcholine synthesis rather than endplate enzyme anchoring.

  4. D. COLQ (Best answer)

    COLQ encodes the collagen-like tail that anchors acetylcholinesterase at the endplate.

Takeaway: Congenital transmission disorders require molecularly specific reasoning.

Case sources: [6] [13]

Case 22

A patient accidentally takes several extra doses of pyridostigmine and develops worsening weakness, sweating, diarrhea, bradycardia and excessive salivation. Which possibility needs urgent assessment?

Show answer and explanations for case 22
  1. A. A usual maintenance dose by itself proves overdose (Why this does not fit)

    The dose error and clinical findings, not a usual dose in isolation, support this assessment.

  2. B. Cholinergic toxicity (Best answer)

    An excess-dose history together with muscarinic findings and weakness supports cholinergic toxicity.

  3. C. A pure sensory neuropathy (Why this does not fit)

    That does not explain the cholinergic autonomic findings.

  4. D. A reason to give additional pyridostigmine immediately (Why this does not fit)

    More acetylcholinesterase inhibition could worsen suspected toxicity.

Takeaway: Excess secretions and gastrointestinal activity help distinguish toxicity from isolated worsening MG.

Case sources: [8]

Case 23

A patient with MG is planning pregnancy and asks whether to stop all medicines. What is the best general approach?

Show answer and explanations for case 23
  1. A. Every immune therapy is equally safe throughout pregnancy (Why this does not fit)

    Drug risks and clinical circumstances differ.

  2. B. Stop every treatment regardless of respiratory or bulbar symptoms (Why this does not fit)

    Uncontrolled MG can itself create serious maternal risks.

  3. C. Switch automatically to mycophenolate (Why this does not fit)

    Mycophenolate is avoided in pregnancy because of fetal risk.

  4. D. Coordinate medication review while maintaining disease control (Best answer)

    Neurologic and obstetric review should assess each medicine; abrupt universal withdrawal can compromise disease control.

Takeaway: Pregnancy requires an individualized treatment plan, not a blanket stop rule.

Case sources: [8]

Case 24

After IVIG, an asymptomatic patient has a low sodium result by an indirect laboratory method, high serum protein and a normal sodium concentration on a direct ion-selective electrode. Which explanation fits?

Show answer and explanations for case 24
  1. A. Immediate sodium correction regardless of confirmation (Why this does not fit)

    Treatment based only on an artifactual value could be inappropriate.

  2. B. A normal direct measurement proves excess water in plasma (Why this does not fit)

    It argues against a low sodium concentration in plasma water in this scenario.

  3. C. Hyperproteinemia-related pseudohyponatremia (Best answer)

    The method discrepancy and preserved direct measurement support a measurement artifact from increased non-water plasma components.

  4. D. Every low sodium result after IVIG is true hypotonic hyponatremia (Why this does not fit)

    IVIG-associated laboratory changes have multiple possible mechanisms; this direct-versus-indirect discrepancy matters.

Takeaway: Confirm tonicity and the measurement method before attributing a post-infusion sodium result.

Case sources: [9] [10]

Case 25

Within a week of starting corticosteroids, a patient with MG has increased bulbar weakness. Which response is appropriate?

Show answer and explanations for case 25
  1. A. This always proves steroid allergy (Why this does not fit)

    Early worsening does not automatically indicate allergy.

  2. B. Assess urgently for recognized transient early worsening and respiratory risk (Best answer)

    Corticosteroids can initially worsen MG; severity and bulbar or respiratory involvement guide monitoring and treatment.

  3. C. Ignore worsening because steroids eventually help (Why this does not fit)

    Bulbar or respiratory deterioration still requires prompt assessment.

  4. D. This is certainly muscle wasting from years of steroid exposure (Why this does not fit)

    The time course does not establish chronic steroid myopathy.

Takeaway: A treatment can help long term while creating an early monitoring need.

Case sources: [4]

Case 27

A patient with MuSK-positive MG has prominent bulbar weakness and an inadequate response to initial immunotherapy. Which specialist-directed option is particularly relevant?

Show answer and explanations for case 27
  1. A. Amifampridine as a direct replacement for all immune treatment (Why this does not fit)

    Its usual indication is symptomatic treatment of LEMS, not this antibody-directed MG strategy.

  2. B. Assume negative AChR antibodies exclude the diagnosis (Why this does not fit)

    MuSK-positive MG is a recognized subtype.

  3. C. Botulinum toxin to increase acetylcholine release (Why this does not fit)

    The toxin reduces release and would not treat this autoimmune weakness.

  4. D. Rituximab (Best answer)

    Consensus guidance identifies rituximab as an important option for MuSK MG with an unsatisfactory response to initial treatment.

Takeaway: Antibody status helps guide immunotherapy.

Case sources: [1] [2]

Case 28

A child has a genetically confirmed congenital myasthenic syndrome. Why should treatment be matched to the specific molecular defect?

Show answer and explanations for case 28
  1. A. A therapy that helps one subtype may be ineffective or harmful in another (Best answer)

    Different presynaptic, synaptic and postsynaptic genetic defects do not respond identically.

  2. B. Every subtype must improve with more acetylcholinesterase inhibition (Why this does not fit)

    Some congenital subtypes can worsen with these medicines.

  3. C. The genetic diagnosis makes respiratory assessment unnecessary (Why this does not fit)

    Clinical severity and respiratory risk still require assessment.

  4. D. All congenital syndromes are caused by maternal AChR antibodies (Why this does not fit)

    Inherited congenital syndromes differ from transient neonatal antibody-mediated weakness.

Takeaway: A shared symptom does not imply a shared treatment mechanism.

Case sources: [1] [6]

Case 29

A patient with fatigable ptosis also develops a new fixed dilated pupil. What should the clinician do?

Show answer and explanations for case 29
  1. A. Evaluate another or additional cause of pupillary dysfunction (Best answer)

    MG generally spares pupils, so a new pupillary abnormality deserves separate assessment.

  2. B. Diagnose botulism from the pupil alone (Why this does not fit)

    One pupillary finding cannot establish a toxin-mediated syndrome.

  3. C. Assume fixed dilation is a routine MG feature (Why this does not fit)

    That is not typical of uncomplicated MG.

  4. D. Use the pupil to quantify receptor antibody concentration (Why this does not fit)

    Pupil size does not measure AChR antibody concentration.

Takeaway: A finding outside the expected pattern should broaden evaluation.

Case sources: [1] [3]

Case 30

A patient asks why weakness persists after botulinum antitoxin. Which statement best explains the treatment limit?

Show answer and explanations for case 30
  1. A. Persistent weakness automatically disproves botulism (Why this does not fit)

    Prolonged weakness is compatible with the disease and its recovery.

  2. B. Mechanical ventilation directly neutralizes the toxin (Why this does not fit)

    Ventilation supports breathing without providing toxin neutralization.

  3. C. Antitoxin prevents additional toxin effects but does not repair already affected terminals (Best answer)

    Established intraneural blockade takes time to recover even after circulating toxin is neutralized.

  4. D. Antitoxin must immediately restore every damaged SNARE protein (Why this does not fit)

    It does not enter the terminal to repair fusion machinery.

Takeaway: Support function while preventing further blockade.

Case sources: [3]

Case 31

A patient receiving an immune-checkpoint inhibitor develops new ptosis and bulbar weakness with chest pain. Which additional concern makes urgent specialist assessment important?

Show answer and explanations for case 31
  1. A. Possible overlap with myositis or myocarditis (Best answer)

    Checkpoint-associated myasthenic illness can coexist with muscle and cardiac inflammation.

  2. B. Chest pain proves the weakness is unrelated (Why this does not fit)

    Both manifestations may belong to an overlapping immune complication.

  3. C. An immune-checkpoint exposure guarantees benign ocular-only disease (Why this does not fit)

    Potential overlap and rapid progression can be serious.

  4. D. Wait for all antibody tests before assessing the heart (Why this does not fit)

    Potential cardiac and respiratory complications need prompt evaluation.

Takeaway: Assess more than the junction when treatment-related immune disease may overlap.

Case sources: [2]

Case 32

A patient with LEMS is being evaluated for FIRDAPSE. Which history is a contraindication in the official prescribing information?

Show answer and explanations for case 32
  1. A. A reduced baseline motor response (Why this does not fit)

    That can be part of LEMS electrophysiology rather than a contraindication.

  2. B. A history of seizures (Best answer)

    FIRDAPSE is contraindicated in patients with a history of seizures.

  3. C. Proximal leg weakness (Why this does not fit)

    This is part of the condition for which symptomatic treatment is considered.

  4. D. Dry mouth caused by LEMS (Why this does not fit)

    Dry mouth is a common autonomic feature of LEMS, not this specific contraindication.

Takeaway: Check the drug-specific contraindications before selecting a mechanistic treatment.

Case sources: [5]

Case 33

After an organophosphate pesticide exposure, a patient has bronchial secretions, miosis, fasciculations and respiratory muscle weakness. Airway support and atropine are being provided. What is the complementary mechanism of pralidoxime?

Show answer and explanations for case 33
  1. A. Direct antagonism of muscarinic acetylcholine receptors (Why this does not fit)

    That describes atropine rather than the enzyme-reactivating action of pralidoxime.

  2. B. Reactivation of susceptible organophosphate-inhibited acetylcholinesterase (Best answer)

    Pralidoxime can restore enzyme activity before the phosphorylated enzyme becomes nonreactivatable; atropine addresses muscarinic receptor effects.

  3. C. Neutralization of botulinum toxin before nerve entry (Why this does not fit)

    That is the role of botulinum antitoxin in a different toxic syndrome.

  4. D. Further inhibition of acetylcholinesterase (Why this does not fit)

    Additional inhibition would worsen the excess acetylcholine problem.

Takeaway: Match atropine to muscarinic effects and pralidoxime to susceptible inhibited enzyme.

Case sources: [12]

Search Bone Wizardry

Quick links